These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8229257)

  • 1. Quantitative brain SPECT in Alzheimer's disease and normal aging.
    Johnson KA; Kijewski MF; Becker JA; Garada B; Satlin A; Holman BL
    J Nucl Med; 1993 Nov; 34(11):2044-8. PubMed ID: 8229257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
    Messa C; Perani D; Lucignani G; Zenorini A; Zito F; Rizzo G; Grassi F; Del Sole A; Franceschi M; Gilardi MC
    J Nucl Med; 1994 Feb; 35(2):210-6. PubMed ID: 8294987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
    Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease.
    Mattman A; Feldman H; Forster B; Li D; Szasz I; Beattie BL; Schulzer M
    Can J Neurol Sci; 1997 Feb; 24(1):22-8. PubMed ID: 9043743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; de Koning I; van der Cammen TJ; Hofman A; Hasan D
    Neurology; 1994 Mar; 44(3 Pt 1):454-61. PubMed ID: 8145915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of neural networks in brain SPECT to diagnose Alzheimer's disease.
    Page MP; Howard RJ; O'Brien JT; Buxton-Thomas MS; Pickering AD
    J Nucl Med; 1996 Feb; 37(2):195-200. PubMed ID: 8667044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: scintigraphic appearance of Tc-99m HMPAO brain spect.
    Lee BF; Liu CK; Tai CT; Chiu NT; Liu GC; Yu HS; Pai MC
    Kaohsiung J Med Sci; 2001 Aug; 17(8):394-400. PubMed ID: 11715838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
    Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive three-dimensional region of interest analysis of HMPAO SPECT brain studies.
    Hooper HR; McEwan AJ; Lentle BC; Kotchon TL; Hooper PM
    J Nucl Med; 1990 Dec; 31(12):2046-51. PubMed ID: 2266407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.
    Soonawala D; Amin T; Ebmeier KP; Steele JD; Dougall NJ; Best J; Migneco O; Nobili F; Scheidhauer K
    Neuroimage; 2002 Nov; 17(3):1193-202. PubMed ID: 12414259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Davis K
    J Nucl Med; 1992 Feb; 33(2):312. PubMed ID: 1732462
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.
    Perani D; Di Piero V; Vallar G; Cappa S; Messa C; Bottini G; Berti A; Passafiume D; Scarlato G; Gerundini P
    J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for assessing the significance of abnormalities in HMPO brain SPECT images.
    Houston AS; Kemp PM; Macleod MA
    J Nucl Med; 1994 Feb; 35(2):239-44. PubMed ID: 8294991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for brain functional study using Tc-99m HMPAO SPECT.
    Momose T; Kosaka N; Nishikawa J; Ohtake T; Watanabe T; Iio M
    Radiat Med; 1989; 7(2):82-7. PubMed ID: 2798934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
    Parnetti L; Lowenthal DT; Presciutti O; Pelliccioli GP; Palumbo R; Gobbi G; Chiarini P; Palumbo B; Tarducci R; Senin U
    J Am Geriatr Soc; 1996 Feb; 44(2):133-8. PubMed ID: 8576501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.
    Karbe H; Kertesz A; Davis J; Kemp BJ; Prato FS; Nicholson RL
    Neuroradiology; 1994; 36(1):1-6. PubMed ID: 8107986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease.
    Hashikawa K; Matsumoto M; Moriwaki H; Oku N; Okazaki Y; Seike Y; Uehara T; Tanabe H; Ohie Y; Kamada T
    J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of Tc-99m HMPAO SPECT for early and late onset Alzheimer's disease: a clinical evaluation of linearization correction.
    Mitsumoto T; Ohya N; Ichimiya A; Sakaguchi Y; Kiyota A; Abe K; Morishita J; Sasaki M
    Ann Nucl Med; 2009 Jul; 23(5):487-95. PubMed ID: 19575281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.